Randomized, controlled, multicenter, multinational phase 2 study of docetaxel (DCT) or AXL1717 treatment in patients with squamous cell carcinoma (SCC) or adenocarcinoma (AC) of non-small cell lung cancer (NSCLC)

被引：1

作者：

Bergqvist, Michael

Bondarenko, Igor

Thuresson, Marcus

Klockare, Maria

Harmenberg, Johan

机构：

[1] Univ Uppsala Hosp, Dept Oncol, Uppsala, Sweden

[2] Dnipropetrovsk City Multifield Clin Hosp 4, Dnepropetrovsk, Ukraine

[3] Statisticon AB, Uppsala, Sweden

[4] Axelar AB, Stockholm, Sweden

[5] Karolinska Inst Sci Park Axelar, Stockholm, Sweden

来源：

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.8091

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8091

引用

页数：1